Molecular mechanisms of drug resistance drug resistance is to reduce the efficacy of a drug in the treatment of a disease or improve the symptoms of the patient. When the drug is not intended to kill or inhibit a pathogen, then the concept corresponding dose failure or drug tolerance. More frequently, the term associated with diseases caused by pathogens. Pathogens are more resistant than pharmaceuticals, they neutralize effectively reduced. When an organism is resistant to more than one drug, it is said that multi-drug resistant. Drug resistance is an example of the evolution in microorganisms. Persons who are not susceptible to the drug effects of drug treatment to survive, and therefore more suitable for fitness as sensitive individuals.
Through the process of natural selection, are resistant properties selected in subsequent offspring in a population that is drug resistant. Multiple drug resistance or multidrug resistance is a prerequisite for a disease-causing organism to various drugs or chemicals that resist a variety of structure and function of the organism to eliminate targeted. Organisms that show multidrug resistance to pathologic cells, including bacterial and neoplastic (tumor cells). Cross-resistance is the tolerance to a toxic substance in the rule as a result of exposure to a similar active substance.
It is a phenomenon that eg pesticides and antibiotics. As an example, rifabutin and rifapin cross-reactions in the treatment of tuberculosis. Various microorganisms have been thousands of years to survive by adapting to their anti-microbial agents. They do this by spontaneous mutation or by DNA transfer. It is this very process that some bacteria can combat the attack of certain antibiotics, making the antibiotic ineffective. These microbes employ several mechanisms to achieve multidrug resistance: no longer a glycoprotein cell wall enzymatic inactivation of antibiotics increasing cell wall permeability to antibiotics Altered destinations of antibiotics increased mutation rate of antibiotic efflux mechanism as a stress reaction, many different bacteria show now remove multidrug resistance, including staphylococci, enterococci , gonococci, streptococci, salmonella, tuberculosis and others. In addition, some resistant bacteria are able to make copies of DNA transfer, a mechanism of resistance to other bacteria, which confer resistance to their neighbors, passing then in a position on the resistance gene.
To limit the development of antibiotic resistance, one should: Use antibiotics only for bacterial infections, identification of the pathogen, if you do not stop with the right antibiotic with broad spectrum of antibiotics antibiotics as soon as the symptoms leave to mend, to the Finish full course of antibiotics is not for most colds, coughs, bronchitis, sinus infections, and eye infections caused by viruses. It is argued that the legislation the Government will increase public awareness about the importance of restrictive use of antibiotics, not only for human clinical use, but also for the treatment of animals for human consumption aid. Schematic representation of the causes and risk factors, such as antibiotic resistance evolves through natural selection. The top section represents a population of bacteria before exposure to an antibiotic. The middle part shows the population directly after exposure, the phase rather than in the selection. The last section shows the distribution of resistance in a new generation of bacteria.
The legend indicates the resistance levels of the individual. Antibiotic resistance may be replaced by horizontal gene transfer, and also the link between mutations in the genome of the pathogen and a rate of about 1 in 108 per chromosomal replication. The antibiotic to the pathogen can be seen as an environmental stress, these bacteria, the mutation so that they will survive to reproduce live. They are then sent to the property to their offspring, which is located in a completely resistant colony. Several studies have shown that patterns of antibiotic usage greatly affect the number of resistant organisms which develop themselves. Overuse of broad-spectrum antibiotics, such as second-and third-generation cephalosporins, greatly accelerated the development of methicillin resistance. Other factors include the resistance to wrong diagnosis, unnecessary rules, improper use of antibiotics in patients who impregnate household items and toys with a low dose of antibiotics and the antibiotics by mouth in animal husbandry for growth promotion. Also unhealthy practices in the pharmaceutical manufacturing industry can contribute to the likelihood of the creation of antibiotic-resistant strains.
The researchers have demonstrated recently to play the bacterial protein LexA may play a central role in the acquisition of bacterial mutations. Drug resistance occurs in several classes of pathogens: bacteriaâ? Antibiotic endoparasites virusesâ? Resistance to antiviral drugs mushrooms cancer mechanisms, the four major mechanisms by which microorganisms exhibit resistance to antimicrobials are: drug inactivation or modification: eg enzymatic inactivation of penicillin G in some penicillin-resistant bacteria through the production of?-Lactamases.
Antibiotic modification is the best known: the resistant bacteria retain the same goal as sensitive strains sensitive to antibiotics but the antibiotic is prevented from reaching. This happens, for example with the lactamases    lactamase enzymatically cleaves the four membered lactam ring, thus the antibiotic inactive. About described species of 200  lactamase was (Table).
Most lactamases act to some degree against both penicillins and cephalosporins, while others are more specific fact cephalosporinases (eg AmpC enzyme in Enterobacter spp) or penicillinases (), for example, Staphylococcus aureus penicillinase. Â lactamases are widespread among many bacterial species (both Gram-positive and Gram-negative) and to different degrees of inhibition by-lactamase inhibitors such as clavulanic acid. Change the target site: eg change of PBPâ? the binding target location penicillinsâ? in MRSA and other penicillin-resistant bacteria.
Changes in the primary site of action may mean that the antibiotic penetrates the cell and reaches the destination, but is not able to inhibit the activity of the target due to structural changes in the molecule. Enterococci are considered as naturally resistant to cephalosporins because the enzymes responsible for cell wall synthesis (production of the polymer peptidoglycan) than penicillin-binding proteins have low affinity for them and are therefore not considered to inhibit known. Most strains of Streptococcus pneumoniae are highly susceptible to both penicillins and cephalosporins may also DNA from other bacteria, which changes the enzyme so that they develop a low affinity for penicillins and hence will not acquire resistant to inhibition by penicillin. Â The modified enzyme synthesized peptidoglycan yet but it now has a different structure.
 mutants of Streptococcus pyogenes that are resistant to penicillin and express altered penicillin-binding proteins are selected in the laboratory, but it has not been seen in patients, possibly because the cell wall is no longer bind the anti-phagocytic M protein. Change in the metabolic pathway: eg some sulfonamide-resistant bacteria do not require para-amino benzoic acid (PABA), an important precursor for the synthesis of folic acid, and nucleic acids in bacteria inhibited by sulfonamides. Instead, like mammalian cells, they turn to use preformed folic acid. Quick run-out time: Active efflux is a mechanism responsible for the extrusion of toxic substances and antibiotics outside the cell, this is as an essential part of xenobiotic metabolism. This mechanism is important in medicine because they can contribute to bacterial resistance to antibiotics.
Efflux systems function in an energy-dependent mechanism (active transport) pump unwanted toxic substances through specific efflux pumps. Several efflux systems are drug-specific, while others may accommodate several drugs, thereby contributing to bacterial multidrug resistance (MDR). There are three known mechanisms of fluoroquinolone resistance. Some types of efflux pumps can act to decrease intracellular quinolone concentration. In gram-negative bacteria, plasmid-mediated resistance genes produce proteins that protects DNA gyrase binding to it before the effect of quinolones. Finally, can changes in important locations in the DNA gyrase and topoisomerase IV, its binding affinity to quinolones fall, decreasing effectiveness of the drug. Bacterial efflux pumps are proteinaceous transporter in the cytoplasmic membrane of all types of cells localized.
They are active transporter means that they are a source of chemical energy needed to fulfill their function. Some are primary active transporters using adenosine triphosphate hydrolysis as an energy source, while other secondary active transporters (Uniport, symporter or antiporter), in which transport is coupled to an electrochemical potential difference by pumping hydrogen or sodium ions produced from the cell. Bacterial efflux transporters are five large superfamilies, the amino acid sequence and used the energy source, are classified by their export substrates based on: The major facilitator superfamily (MFS), ATP-binding cassette superfamily (ABC); The little family multidrug Resistance (SMR), the resistance-nodulation-cell division superfamily (RND) and the multi-antimicrobial extrusion protein family (MATE). Of these, only the ABC transporter superfamily are primary, the rest is secondary transporters use proton or sodium gradient as a source of energy.
While MFS dominates in Gram-positive bacteria, the RND family is unique in Gram-negative. In the case of imipenem resistant Pseudomonas aeruginosa, the absence of the specific D2 porin confers resistance, as imipenem not penetrate into the cell. This mechanism is also seen with low resistance to fluoroquinolones and aminoglycosides. Increased efflux via an energy-requiring transport pump is an established method of resistance to tetracyclines and is supported by a variety of genes, such as tet (A) is coded to be distributed in Enterobacteriaceae. Function Although antibiotics are clinically important substrates of the efflux systems, it is likely that most other efflux pumps have natural physiological functions. Examples include: the E. coli AcrAB efflux system, which is a physiological role of bile acids and fatty acid pumps out of its low toxicity. The MFS family Ptr pump in Streptomyces pristinaespiralis autoimmunity seems to be a pump for this organism, when it refers to the production of pristinamycin I and II AcrABâ? TolC system in E. coli is suspected of a role in the transport of calcium channel components in the E. coli membrane. The MtrCDE system plays a protective role by gonorrhoeae resistance to faecal lipids in rectal isolates of Neisseria.
The AcrAB efflux system of Erwinia amylovora is responsible for the virulence of this organism is important to plant (host), colonization, and resistance against plant toxins. The ability of the efflux systems, a large number of compounds that can be seen other than their natural substrates, probably because substrate recognition is based on the physico-chemical properties such as hydrophobicity, aromaticity and ionizable character than on defined chemical properties, as in the classical enzyme-substrate or ligand-receptor recognition. The fact that many antibiotics amphiphilic molecules – are both hydrophilic and hydrophobic character, they are easily recognized by many efflux pumps. Impact on the effects of antibiotic efflux mechanisms of antimicrobial resistance is large, this is usually the following: the genetic elements encoding efflux pumps can be encoded on the chromosomes and / or plasmids, thus contributing to both intrinsic (natural) and acquired resistance or due.
As a key mechanism of resistance efflux pump genes can survive a hostile environment (for example) in the presence of antibiotics, which allows for selection of mutants with an overexpression of these genes. His transpoable on genetic elements such as transposons or plasmids is also advantageous for the microorganisms, as it allows easy sharing of genes between distant species efflux. Antibiotics can be used as inducers and regulators of the expression of efflux pumps. Expression of multiple efflux pumps in a particular species of bacteria can cause a wide spectrum of resistance when one gives to the common substrates, some multi-drug efflux pumps, which can efflux pump resistance against a broad spectrum of antibiotics. Molecular epidemiology of resistance genes in bacterial resistance can be intrinsic or acquired. Intrinsic resistance is a naturally occurring feature of the biology of the organism, such as vancomycin resistance in E. coli. Acquired resistance occurs when a bacterium that was sensitive to antibiotics develops resistance may happen by this mutation or by acquisition of new DNA.
The mutation is a spontaneous event that is independent of whether antibiotics occurs far. A bacterium carrying out such a mutation is a big advantage, as the sensitive cells are quickly killed by the antibiotic, so that a resistant subpopulation. Transferable resistance was recognized in 1959, Â when found resistance genes in E coli, shigella and transferred via plasmids. Plasmids are self-spreading has circular DNA pieces, smaller than the bacterial genome, which encodes the transfer of replication in a different bacterial strain or species. You can wear and the transfer of several resistance genes, which may occur on a section of DNA can transfer from one plasmid to another or are in the genome of a transposon (or “jumping genes”).
Since the spectrum of bacteria, the plasmids can spread is often limited transposons are important in the dissemination of resistance genes on such boundaries. Have found the mecA gene in MRSA, can be taken over by the implementation. Plasmid evolution can be complex, but modern molecular techniques can provide an understanding (as is the case with the plasmids that contain gene TETM, and are found throughout the world Neisseria gonorrhoeae). Bacteriophage (virus) can infect bacteria and resistance, and this is often seen in staphylococci. When bacteria die, they release DNA, which can be absorbed by the responsible bacteria, a process known as transformation.
This process is increasingly recognized as important in the environment and is probably the major route for the spread of penicillin resistance in Streptococcus pneumoniae, through the creation of mosaic penicillin-binding protein genes. Origins of resistance genes, the origins of antibiotic resistance genes are because of the dark period, the antibiotics were introduced in the biochemical and molecular basis of resistance was not to be discovered yet. bacteria between 1914Â and 1950A (Murray collection) were collected later found completely susceptible to antibiotics. They have, however, contain A number of plasmids capable of conjugative transfer Neither Murray strains was to sulphonamides, although this was in the mid-1930s, resistance was introduced in the early 1940s, reported in streptococci and gonococci. Â The introduction of streptomycin for treating tuberculosis, was thwarted by the rapid development of resistance by mutation of target genes.
The mutation is present, as the most common mechanism of resistance in Mycobacterium tuberculosis recognized, and the molecular nature of the mutations confers resistance to most anti-TB drugs is not known. A favorable mutations in bacteria can occur through insertion sequences and transposons are mobilized to plasmids and then transferred to different bacterial species. In considering the development and spread of antibiotic resistance genes, it is important to the speed of bacterial multiplication and the continuous exchange of bacteria in animals, humans appreciate knowing and agricultural hosts throughout the world. There is support for the idea that the antibiotic resistance determinants were not currently observed by the bacterial host, times in which the resistance plasmid is derived. DNA sequencing studies lactamases and aminoglycoside inactivating enzymes show that despite the similarities in the protein studies of the two families, that there are considerable differences in sequence. Â There is not the evolutionary time frame must be less than 50Â years it possible for a model of evolution by mutation alone from the common ancestor genes could have occurred can be derived.
You need to have a large and diverse gene pool probably come already occurring bacteria in the environment. Many bacteria and fungi that produce antibiotics possess resistance factors, which found the bacteria in clinical . exchanging genes are similar, could be present in the soil or, more likely, in the intestines of humans and animals. It was noted that the commercial antibiotic preparations contain DNA from the producing organism and antibiotic resistance gene sequences by be identified using polymerase chain reaction. genes, either in nature or is already in place quickly through mutation. Rapid mutation was caused by (a) the TEM to a lactamase, leading to an extension of the substrate profile views, include third generation cephalosporins (first reported in Athens in 1963, a year after the introduction of ampicillin) and (b) IMI-1 lactamase (reported from a California hospital before imipenem was approved for use in the United States). The selection pressure is heavy and indiscriminate use is of antibiotics, especially in medical practice is probably responsible, although agricultural and veterinary use for resistance in human pathogens. The addition of antibiotics to animal feed or water, either for growth promotion or, more importantly for the mass production of treatment or prevention (or both treatment and prophylaxis) in the factory, farm animals, with an unquantified effect on resistance levels.
Bacteria clearly a miraculous series of biochemical and genetic systems for ensuring the development and spread of antibiotic resistance. resistance mechanism to some important Antibiotics 1st    Ã?-Ã-lactam resistance?-lactam antibiotics belong to a family of antibiotics, which is characterized by a Ã,?-lactam ring. penicillins, cephalosporins, clavams (or oxapenams), cephamycins and Carbapenems are members of this family. The integrity of the Ã?-lactam ring is essential for the activity to catalyze the results in the inactivation of a number of transpeptidase that the final cross-linking reactions of peptidoglycan synthesis. resisting Ã?-lactams in clinical isolates is before are all on the hydrolysis of the antibiotic through a Ã?-lactamase. Mutational events that may lead to the change in the PBP (penicillin binding proteins) or cellular permeability also mean that Ã?-lactam resistance.
Ã? one-lactamases heterogeneous group of enzymes. Several classifications have been following its hydrolytic spectrum, susceptibility to inhibitors, genetic localization suggested (plasmidic or chromosomal), gene or protein amino acid sequence. The functional classification of Ã?-lactamases of Bush, Jacoby and Medeiros (1995) proposed that four groups, depending on the substrate and inhibitor profiles. group defined 1 cephalosporinases not well inhibited by clavulanic acid, group 2 penicillinases, cephalosporinases and broad-Ã?-lactamases, which are generally inhibited by active site -directed Ã?-lactamase inhibitors, Group 3 metallo-Ã?-lactamases that hydrolyze penicillins, cephalosporins, and carbapenems and are poorly inhibited by almost all Ã?-lactam-containing molecules, Group 4 penicillinases that are not well stabilized be by clavulanic acid. sub-groups were also defined prices after the hydrolysis of carbenicillin and cloxacillin (oxacillin) of group 2 penicillinases.
The classification originally proposed by Ambler (1980) introduced and is based on the amino acid sequence recognized four molecular classes designated A to D classes A, C and D to collect evolutionarily distinct groups of serine enzymes, and the Class B zinc-dependent ( “EDTA-inhibited”) enzymes. Fig: Ã? marker lactamases Common B-lactam resistance in molecular biology, the gene for The bla TEM-1 Ã?-lactamase is encountered ampr markers used in molecular biology (pBR and pUC plasmids). plasmidic TEM-1 is a widespread Ã?-lactamase that attacks narrow spectrum cephalosporins, cefamandole and cefoperazone temocillin and all anti-Gram-negative bacteria with the exception of penicillins. aminothiazol chephalosporins, cephamycins, monobactams and carbapenems are resistant to their activity.
It belongs to the Bush-Jacoby-Medeiros group 2b and the molecular class A. The TEM-1 – enzyme was first isolated from an E. coli, reported in 1965 and is now the most common Ã?-lactamase found in Enterobacteriaceae. resistance in more than 50% of ampr E. coli clinical isolates is due to the TEM-1. The most advanced Spectrum Ã?-lactamases (ESBLs) derived from TEM-1, TEM-2 and SHV-1 mutations produce 1 – to 4-amino-acid sequence substitutions. 2 Â Â Â aminoglycoside resistance aminoglycosides (streptomycin, kanamycin, tobramycin, amikacin,. ..) are compounds that are the presence of an amino sugar ring aminocyclitol marked in relation to their structure.’s The bactericidal activity is attributed to the irreversible binding to the ribosome, although their interaction is with other cellular structures and metabolic processes that account was worn.
They have a broad spectrum antimicrobial. They are against aerobic and facultative aerobic gram-negative bacteria and some Gram-positive bacteria that are staphylococci. Aminoglycosides inactive against anaerobes and rikettsia. spectinomycin, which is an amino sugar aminocyclitol the devoided by extension who in the family of aminoglycosides. In addition, different from them not by their bacteriostatic ativity and by the way they campaign. Spectinomycin acts on protein synthesis in the ribosome-mRNA interaction and to do it a mistranslation as aminoglycosides. Three mechanisms of resistance have been identified, namely ribosome modification, reducing permeability and inactivation of the medicines that by aminoglycoside-modifying enzymes. The latter mechanism is of most clinical importance, since the genes of aminoglycoside-modifying enzymes can be spread by plasmids or transposons. Ribosome Change High resistance to streptomycin and spectinomycin from single step mutations in chromosomal genes for ribosomal proteins: Result rpsl (or road), rpsD (or Rama or sud2) RPSE (eps or spc or SPCA). Strč mutations in (or Strb) produce a low-level streptomycin resistance.
Decreased permeability Missing or change in aminoglycoside transport, lack of membrane potential change in the LPS (lipopolysacchaccarides) phenotype can result in a cross-resistance to all aminoglycosides. inactivation of aminoglycosides These enzymes are essentially classified into three classes depending on the type change: AAC (acetyltransferases), ANT (nucleotidyltransferases or adenyltransferase), APH (phosphotransferases). This classification has been extensively by Shaw et al. (1993) are checked. Frequently aminoglycoside resistance markers in molecular biology ant (3”)-Ia (synonyms: aadA, AAD (3”) (9.)) used confers resistance to streptomycin and spectinomycin. The gene was in collaboration with several transposons (TN7, TN21, found …) and is ubiquitous in Gram-negative bacteria. aph (3 ‘)-II (synonyms: APHA-2, npt II) confers resistance to km (kanamycin), Neo (neomycin), PRM (paromomycin), RSM (ribostamycin), but ( butirosin), GMB (GentamycinB).
This gene is rare in clinical isolates. aph (3 ‘)-II is associated with transposon Tn5 and observed in Gram-negative bacteria and Pseudomonas sp. However, isolates its relative abundance in environmental matters KanR seems low to be (RECORBET et al., 1992, Leff et al., 1993; Smalla et al., 1993). aph (3 ‘)-III (synonyms: nptIII) confers resistance to km (kanamycin), Neo (neomycin) PRM (paromomycin), RSM (ribostamycin) lvdm (lividomycin), but (butirosin), GMB (GentamycinB). Amk (amikacin) and ISP (Isepamicin) are also changes in vitro, but detected by standard NCCLS susceptibility to resistance distributed only at a low level that many strains expressing true. aph (3 ‘)-III under the Gram-positive bacteria, but has been observed in Campylobacter spp. nptIII is not frequently used in molecular biology, but on Some Agrobacterium vectors for plant transformation (Bevan, 1984) are found. 3 Â Â Â tetracycline resistance tetracyclines (tetracycline, doxycycline, minocycline, oxtetracycline) are antibiotics which inhibit the multiplication of bacteria by termination of protein synthesis.
They are often used for the last forty years as therapeutic agent in human and veterinary medicine but also as growth promoters in animal breeding. The emergence of bacterial resistance to these antibiotics are used today is limited. Three different specific mechanisms of tetracycline resistance have been identified: tetracycline efflux, ribosome protection and tetracycline modification. tetracycline efflux is achieved by an export protein from the major facilitator superfamily (MFS). The export protein was shown as a function of electroneutral antiport system which catalyzes the exchange of tetracycline-divalent metal cation complex for a proton. In Gram-negative bacteria export protein 12 TMS (transmembrane fragments containing), while in Gram-positive bacteria shows have 14 TMS. ribosome protection mediated by a soluble protein, with the shares homolgy GTPases participate in protein synthesis, namely EF-Tu and EF-G. The third mechanism involves a cytoplasmic protein that is chemically modified tetracycline. This reaction only in the presence of oxygen and NADPH site and not function in the natural host (Bacteroides).
The first two mechanisms are the most widespread and most of their genes are normally acquired via transferable plasmids and / or transposons. These two mechanisms were observed in both aerobic and anaerobic Gram-negative or Gram-positive bacteria indicate their wide distribution among bacterial Empire. sequenced up to now, over sixty-one tetracycline resistance genes and thirty-two classes of genes) does not identify producers and producers (Streptomyces. Each new class is identified by its inability to hybridize with any of the known genes under tet strict conditions. A new nomenclature for the resistance factors has been proposed for the future with the SB Levy Group, the designation of Common tetracycline resistance markers in molecular biology are several factors to coordinate resistance to tetracycline are used in molecular biology.
Most meet the tetA genes of classes A (RP1, RP4 and Tn1721 derivatives), B (Tn10 derivatives) and C (pSC101 or pBR322 derivatives) encoding a tetracycline efflux system. These genes are regulated by a repressor protein (TetR). This function was also used to construct tightly regulated, high level is obtained through the use of regulatory elements of the Tn10 tetracycline operon (Tet and Tet OffTM ontm Expression Systems & Cell Lines, Clontech). TETM The gene from Tn916
